-
Valvi, S, Hansford, JR.
Radiomics-A new age of presurgical assessment to improve outcomes in pediatric neuro-oncology..
Neuro Oncol
24(6)
:
995 -996
2022
view publication
-
van Tilburg, CM, Heiss, M, Øra, I, Beilken, A, Dirksen, U, Gottardo, NG, Khuong-Quang, D-A, Hansford, J, Hutter, C, Van der Lugt, J, et al.
Phase I results of the INFORM2 combination study of nivolumab and entinostat in children and adolescents: INFORM2 NivEnt..
Journal of Clinical Oncology
40(16_suppl)
:
10034 -10034
2022
view publication
-
Landi, DB, Ziegler, DS, Franson, AF, Baxter, PA, Leary, S, Larouche, V, Waanders, AJ, Van der Lugt, J, McCowage, GB, Doz, F, et al.
FIREFLY-1 (PNOC 026): A phase 2 study to evaluate the safety and efficacy of tovorafenib (DAY101) in pediatric patients with RAF -altered recurrent or progressive low-grade glioma or advanced solid tumors..
Journal of Clinical Oncology
40(16_suppl)
:
tps10062 -tps10062
2022
view publication
-
Lamoureux, A-A, Fisher, MJ, Lemelle, L, Pfaff, E, Pfister, SM, Sturm, D, Jones, DTW, Orbach, D, Raskin, S, Drilon, AE, et al.
Clinical characteristics and outcome of a large cohort of patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion..
Journal of Clinical Oncology
40(16_suppl)
:
2052 -2052
2022
view publication
-
Lazow, MA, Fuller, C, DeWire, M, Lane, A, Bandopadhayay, P, Bartels, U, Bouffet, E, Cheng, S, Cohen, KJ, Cooney, TM, et al.
Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry..
Neuro Oncol
24(5)
:
821 -833
2022
view publication